Heather S Mitchell
Affiliation: Victorian Cervical Cytology Registry
- Influences on the risk of recurrent high grade cervical abnormalityH Mitchell
Victorian Cervical Cytology Registry, Carlton, South Victoria, Australia
Int J Gynecol Cancer 12:728-34. 2002..We conclude the risk of recurrent high-grade epithelial abnormality is related to the age and degree of abnormality on the incident biopsy. Screening policies should acknowledge the risk does not diminish with time...
- Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical statusH S Mitchell
Victorian Cervical Cytology Registry, Carlton South, Victoria, Australia
Cancer 93:237-40. 2001..There is concern that Papanicolaou (Pap) smears without an endocervical component may be associated with the incomplete detection of abnormalities...
- Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screeningHeather Mitchell
Victorian Cervical Cytology Registry, Melbourne, Victoria, Australia
Cancer 99:336-41. 2003..The impact of improved endocervical sampling and better recognition of the cytologic precursors to adenocarcinoma during the 1990s in reducing the risk of adenocarcinoma is currently unknown...
- Outcome after a cytological prediction of glandular abnormalityHeather S Mitchell
Victorian Cervical Cytology Registry, 752 Swanston Street, Carlton, Victoria 3052, Australia
Aust N Z J Obstet Gynaecol 44:436-40. 2004..The availability of population-based Australian data on the outcome after a cytology prediction of glandular abnormality was considered relevant to revising the recommended investigations for women with these abnormalities...
- Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control studyHeather Mitchell
Victorian Cervical Cytology Registry, Macfarlane Burnet Institute for Medical Research and Public Health, and Victorian Cytology Service, Melbourne, Australia
Acta Cytol 48:595-600. 2004..To determine whether women diagnosed with adenocarcinoma in situ (AIS) of the cervix are as well screened as healthy control women...
- Laboratory performance measures: evidence against low-risk women explaining low detection rates of high-grade abnormalitiesH S Mitchell
Victorian Cervical Cytology Registry, Carlton South, Vic, Australia
Cytopathology 16:77-81. 2005..This study was undertaken to explore the hypothesis that a low-risk group of women were screened by Victorian laboratories not meeting the recommended minimum standard for the detection of high-grade abnormalities...
- Outcome after a cervical cytology report of low-grade squamous abnormality in AustraliaHeather Mitchell
Victorian Cervical Cytology Registry, Carlton South, Australia
Cancer 105:185-93. 2005..The current study was undertaken to assist with providing an evidence-based approach to the management of women with cervical cytology reports of low-grade squamous abnormality as used in the Australian organized screening program...
- How much cervical cancer is being prevented?Heather S Mitchell
Med J Aust 178:298. 2003
- Prevention of cervical cancerAnnabelle Farnsworth
Douglass Hanly Moir Pathology, 95 Epping Road, North Ryde, NSW 2113, Australia
Med J Aust 178:653-4. 2003..For a sustainable program, cost-containment issues need to be considered; screening interval, management of screen-detected abnormalities, and new technologies are the critical drivers of cost...